发明名称 New 3-phenyl-1-(phenylsulfonyl)-1,3-dihydro-2H-indol-1-one derivatives, are arginine-vasopressin and/or oxytocin receptor ligands useful e.g. for treating cardiovascular or central nervous system disorders
摘要 Piperazino- or homopiperazino-substituted 3-phenyl-1-(phenylsulfonyl)-1,3-dihydro-2H-indol-1-one derivatives (I) are new. Indolone derivatives of formula (I) and their mineral or organic acid addition salts, solvates and/or hydrates are new. n = 1 or 2; X = CH2, O, NH, OCH2, NHCH2 or NHCH2CH2; R1 = halo, 1-4C alkyl or 1-4C alkoxy; R2 = H, halo, 1-4C alkyl, 1-4C alkoxy or CF3; R3 = halo, 1-3C alkyl, 1-3C alkoxy, CF3 or OCF3; R4 = H, halo, 1-3C alkyl or 1-3C alkoxy; R5 = 2-, 3- or 4-pyridinyl, 2-, 4- or 5-pyrimidinyl, 2-pyrazinyl or 3- or 4-pyridazinyl; R6, R7 = 1-4C alkoxy. Independent claims are also included for: (1) the preparation of (I); and (2) new 1-unsubstituted indolone derivative intermediates of formula (IV) and their mineral or organic acid addition salts, as pure optical isomers or their mixture. X' = CH2 or OCH2.
申请公布号 FR2827604(A1) 申请公布日期 2003.01.24
申请号 FR20010010359 申请日期 2001.07.17
申请人 SANOFI-SYNTHELABO 发明人 GARCIA GEORGES;ROUX RICHARD;SCHOENTJES BRUNO;SERRADEIL LEGAL CLAUDINE;TONNERRE BERNARD;WAGNON JEAN
分类号 A61K;A61K31/496;A61K31/497;A61K31/501;A61K31/503;A61K31/506;A61K31/55;A61K31/551;A61P;A61P1/04;A61P1/08;A61P1/12;A61P1/14;A61P1/16;A61P3/04;A61P3/06;A61P3/08;A61P3/10;A61P3/12;A61P5/24;A61P5/38;A61P7/04;A61P9/00;A61P9/04;A61P9/08;A61P9/10;A61P9/12;A61P11/00;A61P11/06;A61P13/00;A61P13/02;A61P13/08;A61P13/12;A61P15/00;A61P15/04;A61P15/10;A61P17/02;A61P17/06;A61P19/02;A61P21/00;A61P21/02;A61P25/04;A61P25/06;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/34;A61P27/06;A61P27/12;A61P29/00;A61P29/02;A61P31/00;A61P35/00;A61P37/04;A61P37/08;A61P43/00;C07D;C07D401/12;C07D401/14;C07D403/12;C07D417/12;(IPC1-7):C07D401/14 主分类号 A61K
代理机构 代理人
主权项
地址